LEO announces strategic collaborations for furthering advances in dermatology

LEO Pharma plans to establish five long-term research collaborations in four countries by the end of 2013 in an effort to deliver new treatment options to dermatology patients.

Related Videos
Related Content

The Weekly Roundup: May 29-June 2

June 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

WHO Calls For Caution When it Comes to Using AI For Health

June 2nd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

European Commission Approves Secukinumab for Hidradenitis Suppurativa

June 1st 2023

Addressing Disparities and Ensuring Equitable Care for LGBTQIA+ Patients

June 1st 2023

The Weekly Roundup: May 29-June 2

June 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

WHO Calls For Caution When it Comes to Using AI For Health

June 2nd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

European Commission Approves Secukinumab for Hidradenitis Suppurativa

June 1st 2023

Addressing Disparities and Ensuring Equitable Care for LGBTQIA+ Patients

June 1st 2023

The Weekly Roundup: May 29-June 2

June 2nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

WHO Calls For Caution When it Comes to Using AI For Health

June 2nd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

European Commission Approves Secukinumab for Hidradenitis Suppurativa

June 1st 2023

Addressing Disparities and Ensuring Equitable Care for LGBTQIA+ Patients

June 1st 2023
© 2023 MJH Life Sciences

All rights reserved.